CN102552684A - Functional food for treating hyperplasia of mammary glands in women - Google Patents
Functional food for treating hyperplasia of mammary glands in women Download PDFInfo
- Publication number
- CN102552684A CN102552684A CN2011104459465A CN201110445946A CN102552684A CN 102552684 A CN102552684 A CN 102552684A CN 2011104459465 A CN2011104459465 A CN 2011104459465A CN 201110445946 A CN201110445946 A CN 201110445946A CN 102552684 A CN102552684 A CN 102552684A
- Authority
- CN
- China
- Prior art keywords
- functional food
- cervus elaphus
- elaphus linnaeus
- mammary glands
- food
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a functional food for treating hyperplasia of mammary glands in women, belonging to the technical field of functional biological food. The functional food is characterized in that a preparation method of the functional food comprises the following steps: extracting cervus elaphus linnaeus, heating to 100-110 DEG C and cooling, removing outer shell, skin and tendon, carrying out biological mildewing, and crushing to cervus elaphus linnaeus powder of less than 180 mesh; and adding dioscorea opposita, chrysanthemum, Honeysuckle Flower and Solomonseal Rhizome into the cervus elaphus linnaeus powder, and uniformly mixing to obtain the functional food. The functional food has good relieving and treatment effects on hyperplasia of mammary glands in women, can be administered for a long time as an animal raw material food, and has no any toxic adverse effect and drug dependence.
Description
Technical field
The present invention relates to a kind of functional food of treating hyperplasia of mammary glands, belong to a kind of functional living being food technology field.
Background technology
Cyclomastopathy is the modal cystic hyperplasia of breast of women, and its sickness rate accounts for the first place of mastopathy.Should be the trend that rises year by year by the disease sickness rate in the last few years, the age also more and more becomes younger.Cyclomastopathy is normal breast lobule physiological hypertrophy and subinvolution, and the mammary gland normal configuration gets muddled, and belongs to pathological proliferation; It is neither inflammation one type of disease of non-tumor again; Can be divided into mammoplasia's (mastalgia), adenosis of breast (cyclomastopathy phase, fibroadenosis phase; The fibrosis phase), cystic disease of breast becomes three types.Through before increasing the weight of, be periodically, 5%～15% cystic hyperplasia patient nipple discharge have cystic mass to exist.Be mainly in 30～50 years old women, onset peak is 35～40 years old.
Pathogenic factor is relevant with endocrine disturbance and spirit, environmental factors etc.The endocrine disturbance, the lutein secretion reduces, and it is the major reason of cyclomastopathy morbidity that estrogen increases relatively.The influence of Nervous and Mental Factors such as emotion, anthropic factor or bad life habits: reasons such as sterile, sexual life imbalance at women advanced age, artificial abortion, man and wife's discord, not suckling, cause that mammary gland can not have normally, periodic physiological activity.Dietary structure is unreasonable, causes fatty Excessive Intake like high fat, high-energy diet, drinks and bad life habits such as smoking can be brought out mastopathy.Take for a long time and contain estrogenic health product, contraceptive.
Cyclomastopathy can clinical cure through timely proper treatment; General prognosis bona, if malpractice, or with the passing of time show effect repeatedly touching; The part cystic hyperplasia of breast can be returned ductal epithelium and developed into atypical hyperplasia by typical hypertrophy; Then possibly develop into the hazardness of cystic hyperplasia of breast generation canceration, should enough pay attention to, and the active adoption formulation of first grade of preventive measures.
The woman mammary gland disease sickness rate is higher at present, generally all is to adopt the traditional Chinese medical science, western medical treatment method.Chinese medicine is failed to understand the county to this treatment of diseases effect, and certain toxic and side effects is arranged.The western medicine hyperplasia of mammary glands mostly adopts antibiotic therapy, cures the symptoms, not the disease, and causes after this disease drug withdrawal, can recurrence after a period of time.
Summary of the invention
The purpose of this invention is to provide a kind of with having no side effect of processing as primary raw material of cervus elaphus linnaeus and RHIIZOMA DIOSCOREAE frOm Henan of China and effect significantly, a kind of functional food of treating hyperplasia of mammary glands of no drug dependence.
A kind of functional food of treating hyperplasia of mammary glands; It is characterized in that manufacture method of the present invention is: at first need extract cervus elaphus linnaeus; And heat to 100～110 ℃ of postcooling; After removing shell, remove the rubber band processing, reaching biological mouldization, be crushed to the cervus elaphus linnaeus powder of granularity below 180 orders; RHIIZOMA DIOSCOREAE frOm Henan of China of joining again and Flos Chrysanthemi, Flos Lonicerae, Rhizoma Polygonati, mix homogeneously is processed; Each raw material is following by weight ratio:
Cervus elaphus linnaeus: 55～75g
RHIIZOMA DIOSCOREAE frOm Henan of China: 10～15g
Flos Lonicerae: 5～10g
Flos Chrysanthemi: 5～10g
Rhizoma Polygonati: 5～10g.
The effect of above raw material is narrated as follows:
Cervus elaphus linnaeus: tepor, nontoxic, go into liver, kidney channel, have the function of promoting the circulation of blood, detumescence, kidney tonifying.Cure mainly diseases such as bleb pain toxic swelling, blood stasis are had a pain, asthenia internal injury.Warming and recuperating the kidney-YANG has the effect of promoting blood circulation and detumescence again.Therefore, be usually used in YIN syndrome skin infection and acute mastitis from the beginning of the red and swollen heat pain person, the dissipation role that it is good is incorporated by surgery good medicine commonly used always.
Rhizoma Polygonati: have spleen reinforcing, support lung, kidney tonifying mends smart effect; Can be used for diseases such as weakness of the spleen and stomach, fatigue and asthenia; Can increase coronary flow; Bring high blood pressure down, blood fat reducing and prevent the arteriosclerosis effect, can suppress adrenal gland and wait the blood glucose that causes too high, golden yellow staphylococcus, acid-fast bacilli and some common pathogens are had inhibitory action in various degree.
RHIIZOMA DIOSCOREAE frOm Henan of China: have the effect that strengthening the spleen and tonifying the lung, beneficial essence reinforce the kidney; But regulating YIN and YANG, strengthening the spleen and nourishing the stomach, building body; Mainly contain starch, GL-PP and aminoacid, wherein higher with arginine, methionine, aspartate content, also contain trace element such as ferrum, zinc, copper.
Flos Lonicerae: effect with heat-clearing and toxic substances removing.
Flos Chrysanthemi: be China's conventional Chinese medicine, have dispelling wind, heat clearing away, detoxifcation, repercussive effect.
Instructions of taking: the each 0.6～1.5g of initial stage dose, continuous three weeks; Take 0.3～0.9g mid-term, continuous five weeks; Later stage maintenance dose 0.3～0.6g, continuous one month or two months, take secondary every day, routine cyclomastopathy patient takes surplus clinical 100, and obvious effective rate is more than 85%, and effective percentage is more than 10%, and doing well,improving is more than 2%.
Advantage of the present invention is: theoretical according to Chinese medicine; Selected free of contamination natural valuable ingredient of Chinese medicine is a raw material; The biological purification technique of uses advanced keeps its natural component; Raw material of the present invention is taken from cervus elaphus linnaeus and the RHIIZOMA DIOSCOREAE frOm Henan of China of northeast Cervus nippon Temminck, extracts through high-tech to form, and be a kind of functional living being food.To hyperplasia of mammary glands, mastitis, breast carcinoma and puerperal disease such as agalactia have and alleviate preferably and therapeutical effect, and can take for a long time as a kind of animal material food, without any side effects, do not produce drug dependence.
The specific embodiment
Embodiment 1
At first need extract cervus elaphus linnaeus, and heat, after removing shell, remove the rubber band processing, reaching biological mouldization, be crushed to the cervus elaphus linnaeus powder of granularity below 180 orders to 100 ℃ of postcooling; RHIIZOMA DIOSCOREAE frOm Henan of China of joining again and Flos Chrysanthemi, Flos Lonicerae, Rhizoma Polygonati, mix homogeneously is processed; Each raw material is following by weight ratio:
Cervus elaphus linnaeus: 65g
RHIIZOMA DIOSCOREAE frOm Henan of China: 15g
Flos Lonicerae: 6g
Flos Chrysanthemi: 6g
Rhizoma Polygonati: 6g.
Embodiment 2
At first need extract cervus elaphus linnaeus, and heat, after removing shell, remove the rubber band processing, reaching biological mouldization, be crushed to the cervus elaphus linnaeus powder of granularity below 180 orders to 98 ℃ of postcooling; RHIIZOMA DIOSCOREAE frOm Henan of China of joining again and Flos Chrysanthemi, Flos Lonicerae, Rhizoma Polygonati, mix homogeneously is processed; Each raw material is following by weight ratio:
Cervus elaphus linnaeus: 68g
RHIIZOMA DIOSCOREAE frOm Henan of China: 12g
Flos Lonicerae: 8g
Flos Chrysanthemi: 8g
Rhizoma Polygonati: 6g.
Embodiment 3
At first need extract cervus elaphus linnaeus, and heat, after removing shell, remove the rubber band processing, reaching biological mouldization, be crushed to the cervus elaphus linnaeus powder of granularity below 180 orders to 95 ℃ of postcooling; RHIIZOMA DIOSCOREAE frOm Henan of China of joining again and Flos Chrysanthemi, Flos Lonicerae, Rhizoma Polygonati, mix homogeneously is processed; Each raw material is following by weight ratio:
Cervus elaphus linnaeus: 70g
RHIIZOMA DIOSCOREAE frOm Henan of China: 10g
Flos Lonicerae: 5g
Flos Chrysanthemi: 7g
Rhizoma Polygonati: 8g.
Claims (1)
1. functional food of treating hyperplasia of mammary glands; It is characterized in that: its manufacture method is: at first need extract cervus elaphus linnaeus, and heat to 100～110 ℃ of postcooling, through removing shell, removing the rubber band processing; And after biological mouldization, be crushed to the cervus elaphus linnaeus powder of granularity below 180 orders; RHIIZOMA DIOSCOREAE frOm Henan of China of joining again and Flos Chrysanthemi, Flos Lonicerae, Rhizoma Polygonati, mix homogeneously is processed; Each raw material is following by weight ratio:
Cervus elaphus linnaeus: 55～75g,
RHIIZOMA DIOSCOREAE frOm Henan of China: 10～15g,
Flos Lonicerae: 5～10g,
Flos Chrysanthemi: 5～10g,
Rhizoma Polygonati: 5～10g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011104459465A CN102552684A (en) | 2011-12-28 | 2011-12-28 | Functional food for treating hyperplasia of mammary glands in women |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011104459465A CN102552684A (en) | 2011-12-28 | 2011-12-28 | Functional food for treating hyperplasia of mammary glands in women |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102552684A true CN102552684A (en) | 2012-07-11 |
Family
ID=46400138
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011104459465A Pending CN102552684A (en) | 2011-12-28 | 2011-12-28 | Functional food for treating hyperplasia of mammary glands in women |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102552684A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104069350A (en) * | 2014-07-15 | 2014-10-01 | 张永胜 | Traditional Chinese medicine or health product for treating postpartum milk siltation |
| CN104905771A (en) * | 2015-07-09 | 2015-09-16 | 唐辉 | Electronic pulse diagnosis instrument |
| CN104815124B (en) * | 2015-05-19 | 2018-05-08 | 凉山彝族自治州第二人民医院 | A kind of capsule for treating the proliferation of mammary gland and preparation method thereof |
-
2011
- 2011-12-28 CN CN2011104459465A patent/CN102552684A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104069350A (en) * | 2014-07-15 | 2014-10-01 | 张永胜 | Traditional Chinese medicine or health product for treating postpartum milk siltation |
| CN104815124B (en) * | 2015-05-19 | 2018-05-08 | 凉山彝族自治州第二人民医院 | A kind of capsule for treating the proliferation of mammary gland and preparation method thereof |
| CN104905771A (en) * | 2015-07-09 | 2015-09-16 | 唐辉 | Electronic pulse diagnosis instrument |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1879857A (en) | Medicinal powder for treating mammary gland disease | |
| CN101961449B (en) | Traditional Chinese medicine for treating tinea corporis | |
| CN102552684A (en) | Functional food for treating hyperplasia of mammary glands in women | |
| CN110974925A (en) | Thyroid nodule preparation and preparation method thereof | |
| CN104547736A (en) | Medicine for treating goiter | |
| CN104001131A (en) | Oral traditional Chinese medicine for preventing and treating stress ulcers | |
| CN102755515A (en) | Traditional Chinese medicine decoction for treating hyperplasia of mammary glands | |
| CN103316290B (en) | Oral capsule medicine used for treating women breast hyperplasia | |
| CN102846789B (en) | External application agent for treating alopecia | |
| CN1465387A (en) | Chinese medicine preparation for treating carcinoma of esophagus | |
| CN104997972A (en) | Traditional Chinese medicine preparation for treating radiodermatitis | |
| CN104474455A (en) | Traditional Chinese medicine for treating hyperthyroidism | |
| CN104491511A (en) | Traditional Chinese medicine external-applying preparation for treating hyperplasia of mammary glands | |
| CN106266704A (en) | The Chinese medicine composition for the treatment of gastroenteritis and preparation method | |
| CN106138354A (en) | A kind of Chinese medicine treating cattle inappetence and preparation method thereof | |
| CN105796776A (en) | Drug with effects of reinforcing kidney, strengthening yang and boosting immunity and preparation method of drug | |
| CN104958653A (en) | Traditional Chinese medicine composition for treating tuberculosis | |
| CN105343423A (en) | Eczema treatment medicine and preparation method thereof | |
| CN103623091B (en) | Medicament for external use for treating gout | |
| CN104434998A (en) | Traditional Chinese medicine for treating hyperplasia of mammary glands | |
| CN104689235B (en) | A kind of Chinese medicine composition for treating women scapulohumeral periarthritis | |
| CN101204425B (en) | Medicine for infant obstinate bricanyl | |
| CN104096170A (en) | External-use formula of traditional Chinese medicine ultra-fine powder for weight loss and preparation method of external use formula | |
| CN111658739A (en) | Composition for eliminating breast nodules and preparation method and application thereof | |
| CN113842422A (en) | Medicine for treating hysteromyoma and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C05 | Deemed withdrawal (patent law before 1993) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120711 |